Elevance Health, Inc. (NYSE:ELV) Shares Purchased by Border to Coast Pensions Partnership Ltd

Border to Coast Pensions Partnership Ltd raised its position in Elevance Health, Inc. (NYSE:ELV - Free Report) by 17.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 68,121 shares of the company's stock after buying an additional 10,196 shares during the quarter. Border to Coast Pensions Partnership Ltd's holdings in Elevance Health were worth $25,113,000 as of its most recent filing with the SEC.

A number of other large investors also recently bought and sold shares of ELV. Raelipskie Partnership acquired a new position in shares of Elevance Health during the third quarter worth about $26,000. PSI Advisors LLC acquired a new position in shares of Elevance Health during the 3rd quarter worth $27,000. Eastern Bank purchased a new stake in shares of Elevance Health in the third quarter valued at about $31,000. Dunhill Financial LLC grew its holdings in Elevance Health by 57.8% during the 3rd quarter. Dunhill Financial LLC now owns 71 shares of the company's stock valued at $37,000 after buying an additional 26 shares during the last quarter. Finally, Peterson Financial Group Inc. acquired a new position in shares of Elevance Health in the third quarter worth $44,000. Hedge funds and other institutional investors own 89.24% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on ELV. TD Cowen cut their target price on shares of Elevance Health from $589.00 to $484.00 and set a "buy" rating for the company in a research note on Monday, October 21st. Wells Fargo & Company cut their price objective on shares of Elevance Health from $593.00 to $495.00 and set an "overweight" rating for the company in a research report on Monday, November 4th. Stephens restated an "underperform" rating on shares of Elevance Health in a research report on Friday, October 18th. Morgan Stanley cut their price target on Elevance Health from $643.00 to $551.00 and set an "overweight" rating for the company in a report on Wednesday, October 23rd. Finally, UBS Group reduced their price target on Elevance Health from $605.00 to $555.00 and set a "buy" rating on the stock in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $536.53.

Elevance Health Trading Down 0.3 %

NYSE ELV traded down $1.00 during mid-day trading on Friday, hitting $384.26. The company's stock had a trading volume of 2,696,400 shares, compared to its average volume of 1,457,754. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.50 and a quick ratio of 1.50. Elevance Health, Inc. has a 52-week low of $362.21 and a 52-week high of $567.26. The stock's fifty day simple moving average is $388.02 and its two-hundred day simple moving average is $467.11. The firm has a market capitalization of $89.12 billion, a P/E ratio of 14.01, a price-to-earnings-growth ratio of 1.08 and a beta of 0.84.

Elevance Health (NYSE:ELV - Get Free Report) last announced its quarterly earnings results on Thursday, October 17th. The company reported $8.37 earnings per share for the quarter, missing analysts' consensus estimates of $9.66 by ($1.29). The business had revenue of $44.72 billion for the quarter, compared to analysts' expectations of $43.47 billion. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. The firm's revenue for the quarter was up 5.3% on a year-over-year basis. During the same period last year, the company posted $8.99 earnings per share. Research analysts expect that Elevance Health, Inc. will post 32.96 EPS for the current year.

Elevance Health Company Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.